Delivery Order SPE2DB20D9335-SPE2DB21FW3W7
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of various pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $18,568.80 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31, 2025....
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $8,509.92 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $48,171.42 fixed-price delivery order contract covers a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This award is part of a larger...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $11,840.66, is a firm fixed-price delivery order issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The IDC,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) health facilities nationwide. The $11,089.08 firm fixed-price delivery order is issued under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency's Medical...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. The contract, a $20,858.20 firm fixed-price delivery order, is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. This IDC allows the DLA to issue...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order with a ceiling value of $11,840.00 and an ultimate completion date of April 25, 2024. It is part of a larger...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $74,135.50 firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, covers a comprehensive array of medications, including branded and generic prescription drugs,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of various pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The award, with a ceiling value of $2,467.08, is a firm fixed-price delivery order under the company's existing indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for a Prime Vendor Pharmaceutical program supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA). The $30,695.04 firm fixed-price delivery order covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical supplies....
- SPE2DB20D9335Indefinite Delivery Contract
- SPE2DB20D9335-SPE2DB21FW3W7Delivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, a firm fixed-price delivery order worth $8,559.67, was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, a multi-year indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the diverse medical requirements of military personnel and their dependents across various DoD healthcare facilities. The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for the DLA's pharmaceutical Prime Vendor programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 5/3/21 |